Mucosis B.V. is a clinical stage Dutch biotechnology company developing innovative mucosal vaccines that can be applied needle-free via the nose or mouth.
.@NFIDvaccines: Experts Say Older Adults at Higher Risk for #flu and #RSV; New #Vaccines and Better Uptake Needed - https://t.co/IZpQdL4VV1 https://t.co/xNwxqK7UHt